SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:su-226713"
 

Search: onr:"swepub:oai:DiVA.org:su-226713" > Opioid agonist trea...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Opioid agonist treatment in transition : A cross-country comparison between Austria, Germany and Switzerland

Schwarz, Tanja (author)
Anzenberger, Judith (author)
Busch, Martin (author)
show more...
Gmel, Gerhard (author)
Kraus, Ludwig, 1955- (author)
Stockholms universitet,Centrum för socialvetenskaplig alkohol- och drogforskning (SoRAD),IFT Institut für Therapieforschung, Germany; ELTE Eötvös Loránd University, Hungary; University Medical Centre Hamburg-Eppendorf, Germany
Krausz, Michael (author)
Labhart, Florian (author)
Meyer, Maximilian (author)
Schaub, Michael P. (author)
Westenberg, Jean N. (author)
Uhl, Alfred (author)
show less...
 (creator_code:org_t)
2024
2024
English.
In: Drug And Alcohol Dependence. - 0376-8716 .- 1879-0046. ; 254
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Aims: OAT is a well developed and successful treatment strategy for opioid dependent patients in Europe. It has significantly contributed to the fight against the HIV and HCV pandemics, leading to an increased life expectancy in this population. Building on the OAT experiences in Austria, Germany, and Switzerland and their models of care, the objective of this study is to analyse experiences and changes in patient structures to identify necessary adaptations for the system of care.Methods: We analysed national register-based data from patients receiving OAT during the period spanning from 2010 to 2020 in Austria, Germany (cases), and Switzerland. We examined and compared OAT policies and practice at national levels through a review of literature and publicly available policy documents.Results: Across these three countries, the life expectancy of OAT patients increased substantially. The mean age increased from 33.0 in 2010 to 39.1 in 2020 in Austria, from 35.6 years to 41.5 years in Germany (cases), and from 39.6 to 47.1 in Switzerland, respectively. In all three countries, the percentage of patients/cases aged 60 years and older increased more than tenfold between 2010 and 2020.Conclusions: Integrated support models, reliable care structures, internationally comparable high treatment coverage, flexible prescribing practices, and a wide range of available OAT medications are successful strategies. The experiences in these countries indicate that it is possible to address the complex and chronic nature of opioid dependence and its concurrent mental and physical health challenges, resulting in an increasing life expectancy of OAT patients.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Beroendelära (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Substance Abuse (hsv//eng)

Keyword

Life expectancy among PWUD
OAT models
future needs of ageing PWUD
complex concurrent conditions

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view